Fundraising Fox

Cellectis

Founded 1999 · 241 employees on LinkedIn · 1 known investors

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

AgTechAI & Machine LearningBiotechDeep TechHealthtech

Investors · 1

Ridgeback CapitalMiami

In the news

Cellectis earnings beat by $0.04, revenue fell short of estimates By Investing.cominvesting.com · Aug 2026Cellectis Reports 100.7M Shares, 105.6M Votes | CLLS Stock Newsstocktitan.net · Aug 2026Cellectis to Report Q2 2026 Results Aug. 6 | CLLS Stock Newsstocktitan.net · Jul 2026Cellectis raises $164M for CAR-T and gene-editing programs | Fierce Biotechfiercebiotech.com · Apr 2018

Frequently asked questions

What does Cellectis do?
Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
Who are Cellectis's investors?
Cellectis's investors include Ridgeback Capital.